Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor

American Journal of Clinical Pathology

Volumn 141, Issue 6, 2014, Pages 828-833

  Sehic, Daniel ^a   Ciornei, Cristina D ^b   Gisselsson, David ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blastema; CD56; CITED1; Immunofluorescence; Nephroblastoma; SIX1; Wilms tumor

Indexed keywords

CD56 ANTIGEN; CITED1 PROTEIN; CYTOKERATIN; PROTEIN; TRANSCRIPTION FACTOR SIX1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BLASTEMA; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; EMBRYO (ANATOMY); FEMALE; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY CANCER; MALE; NEPHROBLASTOMA; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STAINING; STROMA; TISSUE MICROARRAY;

BLASTEMA; CD56; CITED1; IMMUNOFLUORESCENCE; NEPHROBLASTOMA; SIX1; WILMS TUMOR;

ADENOCARCINOMA; ADOLESCENT; AGED; ANTIGENS, CD56; CHILD; CHILD, PRESCHOOL; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; NEPHROMA, MESOBLASTIC; NUCLEAR PROTEINS; RHABDOID TUMOR; SARCOMA, CLEAR CELL; SENSITIVITY AND SPECIFICITY; STROMAL CELLS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR;

EID: 84904490641     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPQ8Q0YTHSYZTX     Document Type: Article

References (15)

1. Rivera MN, Haber DA. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer. 2005;5:699-712. (Pubitemid 41486363)
2. Vujanic GM, Sandstedt B. The pathology of Wilms' tumour (nephroblastoma): the International Society of Paediatric Oncology approach. J Clin Pathol. 2010;63:102-109.
3. Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006;24:2352-2358. (Pubitemid 46630667)
4. Pritchard-Jones K. Controversies and advances in the management of Wilms' tumour. Arch Dis Child. 2002;87:241-244. (Pubitemid 34969986)
5. Davidoff AM. Wilms' tumor. Curr Opin Pediatr. 2009;21:357-364.
6. Lovvorn HN, Westrup J, Opperman S, et al. CITED1 expression in Wilms' tumor and embryonic kidney. Neoplasia. 2007;9:589-600. (Pubitemid 47121833)
7. Metsuyanim S, Harari-Steinberg O, Buzhor E, et al. Expression of stem cell markers in the human fetal kidney. PloS One. 2009;4:e6709.
8. Sehic D, Karlsson J, Sandstedt B, et al. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor. Pediatr Blood Cancer. 2012;59:62-68.
9. Yahata T, de Caestecker MP, Lechleider RJ, et al. The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors. J Biol Chem. 2000;275:8825-8834. (Pubitemid 30180238)
10. Li CM, Guo M, Borczuk A, et al. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol. 2002;160:2181-2190. (Pubitemid 34663409)
11. Xu PX, Zheng W, Huang L, et al. Six1 is required for the early organogenesis of mammalian kidney. Development. 2003;130:3085-3094. (Pubitemid 36926948)
12. Boyle S, Shioda T, Perantoni AO, et al. Cited1 and Cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis. Dev Dyn. 2007;236:2321-2330. (Pubitemid 47293774)
13. Ruf RG, Xu PX, Silvius D, et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A. 2004;101:8090-8095. (Pubitemid 38698059)
14. Xu PX. The EYA-SO/SIX complex in development and disease. Pediatr Nephrol. 2013;28:843-854.
15. Lanier LL, Chang C, Azuma M, et al. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol. 1991;146:4421-4426.